TrademarkDir
SAMPLETAINER
LIVE

Serial Number

85563847

Owner

Chembio Diagnostic Systems, Inc.

Attorney

David S. Jacobson

First Use Date

Oct 31, 2012

Filing Date

Mar 8, 2012

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

SAMPLETAINER Trademark

Serial Number: 85563847 • Registration: 4354978

SAMPLETAINER is a trademark filed by Chembio Diagnostic Systems, Inc. on March 8, 2012. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Chembio Diagnostic Systems, Inc. (16 trademarks)

3661 Horseblock Road
Medford, NY 11763

Entity Type: 03

Trademark Details

Filing Date

March 8, 2012

Registration Date

June 18, 2013

First Use Anywhere

October 31, 2012

First Use in Commerce

November 12, 2012

Published for Opposition

August 21, 2012

Goods & Services

A system to collect, store and dispense a sample for a medical diagnostic test comprised of a collection vial

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Apr 15, 2024 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Apr 15, 2024 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Apr 15, 2024 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 15, 2024 APRE
TEAS SECTION 8 & 9 RECEIVED
Dec 6, 2023 E89R
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 20, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 20, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 20, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 20, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 20, 2022 COAR
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jun 18, 2022 REM2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 9, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 9, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 9, 2022 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 15, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 15, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 15, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 15, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 15, 2022 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 9, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 9, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 9, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 9, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 9, 2022 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 4, 2019 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 3, 2019 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 3, 2019 APRE
TEAS SECTION 8 & 15 RECEIVED
Jun 18, 2019 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 18, 2018 REM1
REGISTERED-PRINCIPAL REGISTER
Jun 18, 2013 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 17, 2013 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
May 16, 2013 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 15, 2013 CNPR
ASSIGNED TO EXAMINER
May 8, 2013 DOCK
STATEMENT OF USE PROCESSING COMPLETE
May 3, 2013 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 3, 2013 AITU
USE AMENDMENT FILED
Apr 16, 2013 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 16, 2013 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 16, 2012 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 21, 2012 NPUB
PUBLISHED FOR OPPOSITION
Aug 21, 2012 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 13, 2012 PREV
ASSIGNED TO LIE
Jul 12, 2012 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 22, 2012 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 22, 2012 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 22, 2012 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 22, 2012 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 22, 2012 CNEA
ASSIGNED TO EXAMINER
Jun 18, 2012 DOCK
NOTICE OF PSEUDO MARK MAILED
Mar 15, 2012 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 14, 2012 NWOS

Related Trademarks

More from this Owner

DPP SARS-COV-2 ANTIGEN

DPP SARS-COV-2 ANTIGEN

DPP SARS-COV-2 ANTIGEN

DPP SARS-COV-2 ANTIGEN

DPP SARS-COV-2 IGG/IGM

DPP SARS-COV-2 IGG/IGM

DPP SARS-COV-2 IGG/IGM

DPP SARS-COV-2 IGG/IGM

DPP SARS-COV-2 IGG/IGM

DPP SARS-COV-2 IGG/IGM

DPP SARS-COV-2 ANTIGEN

DPP SARS-COV-2 ANTIGEN